Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now

The biotech boom has become a biotech bust. Many companies still have further to fall, so sell these three before they hit rock bottom.

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

Retirement Stocks: Here’s Where to Invest $1,000 Right Now

Finding a “good” retirement stock suitable for all investors’ portfolios is nearly impossible. Variables depend on your retirement account’s tax structure, age, risk tolerance, and…

The 3 Best Dividend Stocks to Buy in July

Not all stocks pay dividends, and not all dividend payments are equal. Some dividends are more generous than others, and investors seeking to maximize their income need to pay attention to the yield offered on dividend stocks.

BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug

Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.

Why Is Bluejay Diagnostics (BJDX) Stock Up 17% Today?

Bluejay Diagnostics (BJDX) stock is rising higher on Friday with heavy trading despite a lack of news from the medical diagnostic company.

3 Blue-Chip Stocks to Buy at an All-Time Low in July

After their recent selloffs, these blue-chip stocks are trading at bargain prices and are due for a rebound in the second half.

3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True

These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers

3 Super-Safe Dividend Stocks to Buy for the Rest of 2023

Explore three safe dividend stocks for stable investment options in 2023. Find reliability and growth potential in a changing market.

The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today

Caribou Biosciences (CRBU) stock is taking off on Thursday after the gene-editing company announced an investment from Pfizer (PFE).

Why Is Kazia Therapeutics (KZIA) Stock Moving Today?

Kazia Therapeutics (KZIA) stock is on the move Thursday after the company received fast-track designation for its paxalisib program.

Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?

Nymox Pharmaceutical (NYMX) stock is falling on Thursday after the company told investors its shares will be delisted tomorrow.

Why Is VBI Vaccines (VBIV) Stock Down 40% Today?

VBI Vaccines (VBIV) stock is taking a beating on Thursday after the pharmaceutical company announced two stock offerings.

Why Is Akumin (AKU) Stock Up 31% Today?

Akumin (AKU) stock is taking off on Thursday with no news despite investors seeing heavy trading of the company's shares this morning.

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results

Cassava Sciences (SAVA) stock is down 11% on underwhelming results from its clinical trials for its Alzheimer's treatment.

Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?

Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky.

The 3 Best Biotech Stocks to Buy In July

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

Snag Royal Returns: 3 Dividend Aristocrat Stocks to Buy in July

There are three dividend-aristocrat stocks that have a history of steady dividend increases, stable income, and long-term growth.